LGC labs group seeks £500m for secondary LBO by KKR

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
LevFin
LevFin Leveraged Loans

LGC labs group seeks £500m for secondary LBO by KKR

Max Bower
January 06, 2016 12:45 pm
KKR and Avoca

LGC Group, the UK life sciences company, will hold a bank meeting on January 13 for £500m of debt to finance its sale by Bridgepoint to KKR.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated LoansBNP ParibasNews contentLoans and High YieldLevFinLeveraged LoansCommerzbankLevFin Leveraged LoansCrédit AgricolePrivate EquityHSBC
MB
Max Bower
Gift this article